• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

A COMPARATIVE STUDY EVALUATING THE ROLE OF UTILITY OF RED BLOOD CELL COUNT, RED CELL DISTRIBUTION WIDTH, AND NEUTROPHIL/LYMPHOCYTE RATIO AS PROGNOSTIC MARKERS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT MICROVASCULAR COMPLICATIONS

    DR. NIKHILA PHADNIS, Dr. G.S. SHIDDAPUR, DR. PRATEEK HARSH, DR. NIDHI RANA

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 8414-8424

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Aim: The aim of the present study was to evaluate the role of utility of Red Blood Cell count, Red Cell Distribution Width, and Neutrophil/Lymphocyte Ratio as prognostic markers in type 2 Diabetes Mellitus patients with and without microvascular complications.
Methods: The present study is a cross-sectional analytical study. It was undertaken in the Department of Medicine of the parent institute Dr D.Y Patil Medical College, Hospital and Research Centre, Pimpri, Pune, during the period of October 2020 to September 2022 with the aim to evaluate the role of utility of Red Blood Cell count, Red Cell Distribution Width, and Neutrophil/Lymphocyte Ratio as prognostic markers in type 2 Diabetes Mellitus patients with and without microvascular complications.
A total of 300 patients were included in the study- 150 cases, with microvascular complications, and 150 controls, without microvascular complications.
Results: It was evident from the results that majority of patients were in the 51- 60 age group (29%) followed by 61-70years (25%) and 71-80years of age (20%).
Keywords:
    RBC RDW NLR diabetes mellitus microvascula
  • PDF (154 K)
  • XML
(2022). A COMPARATIVE STUDY EVALUATING THE ROLE OF UTILITY OF RED BLOOD CELL COUNT, RED CELL DISTRIBUTION WIDTH, AND NEUTROPHIL/LYMPHOCYTE RATIO AS PROGNOSTIC MARKERS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT MICROVASCULAR COMPLICATIONS. European Journal of Molecular & Clinical Medicine, 9(7), 8414-8424.
DR. NIKHILA PHADNIS, Dr. G.S. SHIDDAPUR, DR. PRATEEK HARSH, DR. NIDHI RANA. "A COMPARATIVE STUDY EVALUATING THE ROLE OF UTILITY OF RED BLOOD CELL COUNT, RED CELL DISTRIBUTION WIDTH, AND NEUTROPHIL/LYMPHOCYTE RATIO AS PROGNOSTIC MARKERS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT MICROVASCULAR COMPLICATIONS". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 8414-8424.
(2022). 'A COMPARATIVE STUDY EVALUATING THE ROLE OF UTILITY OF RED BLOOD CELL COUNT, RED CELL DISTRIBUTION WIDTH, AND NEUTROPHIL/LYMPHOCYTE RATIO AS PROGNOSTIC MARKERS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT MICROVASCULAR COMPLICATIONS', European Journal of Molecular & Clinical Medicine, 9(7), pp. 8414-8424.
A COMPARATIVE STUDY EVALUATING THE ROLE OF UTILITY OF RED BLOOD CELL COUNT, RED CELL DISTRIBUTION WIDTH, AND NEUTROPHIL/LYMPHOCYTE RATIO AS PROGNOSTIC MARKERS IN TYPE 2 DIABETES MELLITUS PATIENTS WITH AND WITHOUT MICROVASCULAR COMPLICATIONS. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 8414-8424.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 19
  • PDF Download: 26
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus